|
Name |
3aalpha-Hydroxy-5abeta-methyl-6beta-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-3a,4,5,5a,6,7,8,8aalpha-octahydro-2H-indeno[5,4-b]furan-2-one
|
| Molecular Formula | C21H32O3 | |
| IUPAC Name* |
(3aS,5aR,6R,8aR)-6-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-3a-hydroxy-5a-methyl-4,5,6,7,8,8a-hexahydrocyclopenta[e][1]benzofuran-2-one
|
|
| SMILES |
C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@]3(C2=CC(=O)O3)O)C
|
|
| InChI |
InChI=1S/C21H32O3/c1-13(2)14(3)6-7-15(4)16-8-9-17-18-12-19(22)24-21(18,23)11-10-20(16,17)5/h6-7,12-17,23H,8-11H2,1-5H3/b7-6+/t14-,15+,16+,17-,20+,21-/m0/s1
|
|
| InChIKey |
UINDYEKBRZRPSX-QPLMFNHESA-N
|
|
| Synonyms |
Demethylincisterol A3; (3aS,5aR,6R,8aR)-3a-Hydroxy-5a-methyl-6-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen- 1-yl]-3a,4,5,5a,6,7,8,8a-octahydro-2H-cyclopenta[e]benzofuran-2-one; 3aalpha-Hydroxy-5abeta-methyl-6beta-[(1R,2E,4R)-1,4,5-trimethyl-2-hexenyl]-3a,4,5,5a,6,7,8,8aalpha-octahydro-2H-indeno[5,4-b]furan-2-one; 3aalpha-Hydroxy-5abeta-methyl-6beta-[(1R,4R)-1,4,5-trimethyl-2-hexenyl]-3a,4,5,5a,6,7,8,8aalpha-octahydro-2H-indeno[5,4-b]furan-2-one
|
|
| CAS | NA | |
| PubChem CID | 15215298 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 332.5 | ALogp: | 4.6 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 46.5 | Aromatic Rings: | 3 |
| Heavy Atoms: | 24 | QED Weighted: | 0.584 |
| Caco-2 Permeability: | -4.649 | MDCK Permeability: | 0.00002840 |
| Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.007 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.142 |
| Blood-Brain-Barrier Penetration (BBB): | 0.089 | Plasma Protein Binding (PPB): | 84.32% |
| Volume Distribution (VD): | 1.141 | Fu: | 2.11% |
| CYP1A2-inhibitor: | 0.053 | CYP1A2-substrate: | 0.352 |
| CYP2C19-inhibitor: | 0.135 | CYP2C19-substrate: | 0.918 |
| CYP2C9-inhibitor: | 0.266 | CYP2C9-substrate: | 0.084 |
| CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.086 |
| CYP3A4-inhibitor: | 0.75 | CYP3A4-substrate: | 0.922 |
| Clearance (CL): | 5.629 | Half-life (T1/2): | 0.106 |
| hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.138 |
| Drug-inuced Liver Injury (DILI): | 0.368 | AMES Toxicity: | 0.075 |
| Rat Oral Acute Toxicity: | 0.875 | Maximum Recommended Daily Dose: | 0.899 |
| Skin Sensitization: | 0.522 | Carcinogencity: | 0.037 |
| Eye Corrosion: | 0.091 | Eye Irritation: | 0.453 |
| Respiratory Toxicity: | 0.678 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004677 | ![]() |
1.000 | D06JPB | ![]() |
0.450 | ||
| ENC002957 | ![]() |
0.760 | D0G8OC | ![]() |
0.450 | ||
| ENC005610 | ![]() |
0.573 | D0G5CF | ![]() |
0.441 | ||
| ENC004864 | ![]() |
0.573 | D0N1TP | ![]() |
0.336 | ||
| ENC006035 | ![]() |
0.573 | D08SVH | ![]() |
0.289 | ||
| ENC006033 | ![]() |
0.531 | D01QUS | ![]() |
0.287 | ||
| ENC003120 | ![]() |
0.531 | D0K5WS | ![]() |
0.277 | ||
| ENC004906 | ![]() |
0.531 | D0Y7LD | ![]() |
0.265 | ||
| ENC002665 | ![]() |
0.526 | D02ZGI | ![]() |
0.246 | ||
| ENC006032 | ![]() |
0.519 | D0I2SD | ![]() |
0.243 | ||